The S-ICD system with no leads in the heart When Boston Scientific announced its acquisition of Cameron Health in early 2012, it proclaimed that Cameron's subcutaneous ICD device with no leads in the ...

Boston Scientific's S-ICD posted fewer lead complications than traditional implants in a new study.--Courtesy of Boston Scientific Boston Scientific's ($BSX) S-ICD ...

Prominent cardiologist Robert Hauser has been known to ruffle feathers in the medical devices industry--and with his recent admonition of Boston Scientific's ($BSX ...

Boston Scientific's Emblem S-ICD, the next generation subcutaneous ICD product, is a novel technology that removes what many believe is the weakest link in implantable cardioverter defibrillators - ...

Boston Scientific CorporationBSX has commenced a global, multi-center UNTOUCHED trial to evaluate the clinical efficiency of its Emblem Subcutaneous Implantable Defibrillator (S-ICD) System. This move ...

The U.S. Food and Drug Administration (FDA) recently granted marketing approval for Boston Scientific Corporation 's BSX Emblem MRI Subcutaneous Implantable Defibrillator (S-ICD) System, in line with ...

MARLBOROUGH, Boston Scientific (NYSE: BSX) has received CE Mark approval for the new EMBLEM™ MRI Subcutaneous Implantable Defibrillator (S-ICD) System, as well as magnetic resonance (MR) conditional ...

Innovative device offers first-line treatment for patients at risk of sudden cardiac arrest MARLBOROUGH, Mass., Boston Scientific Corporation has received FDA and CE Mark approval of the EMBLEM™ ...

Boston Scientific has announced it has completed its acquisition of Cameron Health, according to a news release. Cameron Health, a privately held company based in San Clemente, Calif., is the ...

A company-initiated recall of two models of EMBLEM S-ICD (Boston Scientific) subcutaneous implantable cardioverter defibrillator pulse generators has been categorized as Class I by the US Food and ...